PTPRC and neoplasm: In fact, DOX treatment decreased the absolute abundance of tumor infiltrating lymphocytes, in drug-treated tumors, regardless of tumor response, and significant increases in total number of CD45+ immune cells were only observed in saline-treated tumors (30.0% of tumor cells) compared to both sensitive and resistant tumors (16.85%, 15.92%, respectively) (Figure 2K).